NSE: LICI · 23 October 2026
- Life Insurance Corporation of India (LICI) shares fell 1.87% on October 23, 2026, closing at ₹380.25 after trading in a day's range between ₹377.10 and ₹388.45. The stock opened slightly higher at ₹388.45 compared to its previous close of ₹387.50.
- The corporation announced the launch of three new domestic market products available for sale effective October 19, 2026. These include LIC’s New Jeevan Dhara – II, a non-par individual deferred annuity plan, alongside health and pure risk products LIC’s Health Shield and LIC’s New Cancer Cover. These additions expand the company's retail product offerings across savings and health categories.
- Trading volume was 1.54 times the 20-day average daily volume.
Why is Life Insura Corp Of India share price falling on 23 October 2026?
Life Insurance Corporation of India (LICI) shares fell 1.87% on October 23, 2026, closing at ₹380.25 after trading in a day's range between ₹377.10 and ₹388.45. The stock opened slightly higher at ₹388.45 compared to its previous close of ₹387.50.
The broader market experienced downward pressure, with the Nifty falling 0.9%. LICI's decline reflects continued near-term weakness, adding to a 5-day return of -3.49% and a 20-day return of -6.69%, placing the stock closer to its 52-week low of ₹360.75 rather than its 52-week high of ₹468.48.
Company disclosures show ongoing organizational and product shifts, including the upcoming introduction of three new products starting October 19, 2026—specifically LIC’s New Jeevan Dhara – II, LIC’s Health Shield, and LIC’s New Cancer Cover—alongside recent senior management re-designations and the appointment of five independent directors in early October. While these updates highlight active corporate governance and product expansion, there is no direct evidence linking them as the immediate catalyst for today's price decline.
1.04 crore shares traded by 23 October 2026 · 03:00 PM IST. This compares with a 20-day average daily volume of 67.55 lakh shares (1.54 times). The five-day average daily volume was 83.93 lakh shares. Separately, the NSE report for 22 October 2026 showed 81.87 lakh shares delivered, representing 78.20% of that day’s traded volume. The same report recorded 86,741 trades.
The decline appears consistent with prevailing downward momentum and broader market weakness rather than a specific single corporate catalyst. The stock saw elevated trading volumes above its 20-day average as it retreated further from recent levels.
Latest Company Developments
The corporation announced the launch of three new domestic market products available for sale effective October 19, 2026. These include LIC’s New Jeevan Dhara – II, a non-par individual deferred annuity plan, alongside health and pure risk products LIC’s Health Shield and LIC’s New Cancer Cover. These additions expand the company's retail product offerings across savings and health categories.
Product line expansions reflect ongoing business development efforts, though they form part of standard operations rather than immediate market-moving catalysts.
The board of directors approved the appointment of five independent directors for a four-year term commencing October 7, 2026. The new board members bring extensive leadership experience from regulatory, banking, and public administration backgrounds, including former senior officials from the RBI, central ministries, and financial institutions.
Strengthens corporate governance and board oversight, contributing to institutional continuity over the medium term.
Smt Sonija M.S., previously Chief (Taxation Cell), was re-designated as Chief (I/C) (Finance & Accounts) at the central office in Mumbai. Consequently, she now falls under the definition of Senior Management Personnel of the corporation.
Ensures seamless leadership transition in core financial oversight following recent executive superannuations.
The exchange sought clarification from the company regarding a recent media report. Such a request is a verification step and does not by itself confirm the reported issue.
Appointment of Mr Shailesh Kumar Singh as Non- Executive Independent Director of the company effective. October 07, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 5.50% on 30 September 2026. This compares with 0.84% on 30 June 2026, a change of +4.66 percentage points.
The filing reported 40 MF/UTI holders.
What to Watch Next
- Upcoming board meeting scheduled for November 5, 2026, to consider financial results for the quarter and half-year ended September 30, 2026.
- Market response to the rollout of new product offerings launched on October 19, 2026.
- Delivery volume trends and cash-market participation relative to the 20-day average volume of 1.54x.
- Price action relative to the 52-week low of ₹360.75.
Other Dated Coverage
- Life Insura Corp Of India Share Price Today: Why LICI Is Rising 0.28% | 14 October 2026 — 14 October 2026
- LICI in Focus After Announcing Three New Product Launches; What to Watch Today | 13 October 2026 — 13 October 2026
- Life Insurance Corporation of India in Focus After Board Appoints Five Independent Directo | 8 October 2026 — 8 October 2026
More Life Insura Corp Of India news and dated analysis →
Frequently Asked Questions
What is the latest Life Insura Corp Of India company news?
The corporation announced the launch of three new domestic market products available for sale effective October 19, 2026. These include LIC’s New Jeevan Dhara – II, a non-par individual deferred annuity plan, alongside health and pure risk products LIC’s Health Shield and LIC’s New Cancer Cover. These additions expand the company's retail product offerings across savings and health categories.
How strong was Life Insura Corp Of India’s trading volume?
1.04 crore shares traded, 1.54 times the 20-day average daily volume. The price and volume data are dated 23 October 2026 · 03:00 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.